Contents
The pharmaceutical company Roche wants to renew the infrastructure in the Basel area and invest further in research and production.
In the next two years, the pharmaceutical giant Roche wants to invest in three major projects. This involves another research and development building. Funds will also be used to renew production for synthetic chemical molecules and to build a building for the “Institute of Human Biology”.
Cost: 1.2 billion francs. “The investment is an important step for the future of the Basel location,” says Jürg Erismann, head of the Roche locations in Basel and Kaiseraugst.
Half a billion will flow into the research and development building, which will have 13 floors and be 72 meters high. The building will accommodate laboratory workstations for around 450 researchers.
The investment is an important step for the future of the Basel location.
Over 570 million francs will be spent on the new production building, which is intended to replace the existing site infrastructure. Roche is spending around 100 million on the “Institute of Human Biology” with space for up to 250 researchers.
The planned buildings will be built as part of the existing development plan for the northern area and are expected to be completed by 2030.